Capcium Inc. is a Canadian startup that operates as a pharmaceutical service provider catering to the Pharmaceutical, Over-the-Counter, and Health & Wellness industries. Established in 2014, the company has positioned itself as an innovative, fully licensed value-add service platform provider. Its core focus lies in softgel encapsulation, housed in a new state-of-the-art 150,000 sq ft cGMP manufacturing facility in Montreal, Canada, completed in August 2020. Capcium's strengths lie in its best-in-class team of softgel encapsulation professionals, leveraging decades of manufacturing expertise, customer support experience, and formulation customization knowledge. It offers end-to-end support, from early-stage product development to product commercialization. The company's dedicated in-house R&D team, full-scale development equipment, full-service analytical laboratories, bottling capabilities, and temperature & humidity-controlled warehouses allow it to provide a full turnkey solution to its clients. Capcium's strategic location in Montreal, Canada grants it proximity to airports and ports for overseas export, enabling it to service customers in North America, EMEA, and APAC. The company boasts of providing innovative solutions for firms encountering difficulties in bringing their products to market. With a slogan that emphasizes the journey from molecule to market, Capcium presents itself as a promising player in the health care, manufacturing, and pharmaceutical industries, offering comprehensive solutions to its clientele.
There is no investment information
No recent news or press coverage available for Capcium Inc..